Business & Regulation

News

Pharma, patient advocates clash over Inflation Reduction Act

Pharma reps and patient advocates debated the effect of the IRA on drug pricing and innovation at a Financial Times summit panel.

News

UK negotiates reform for branded drug payment amidst industry dissatisfaction

Comment

Venture financing for APAC early-stage innovator drugs raises one-third less than US

Pricing and Market Access

Colombian healthcare reform aims to upend insurance and shift focus to primary care

Comment

FDA head Califf on tighter accelerated approvals and lower drug prices at JP Morgan

Comment

Downturn for top biopharma companies Q3 market cap as Covid-19 vaccine demand falls

Pricing and Market Access

US midterm election results have multiple implications for the pharma industry

Comment

UK pharma manufacturers with US clients benefit from strengthening dollar

Comment

Novo Nordisk maintains strong growth in T2D against competitor Lilly

GlobalData Healthcare

Comment

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

GlobalData Healthcare

Comment

Bear market hits Europe’s innovator drug venture financing, losing pace with US

GlobalData Healthcare

Comment

Bursting biotech bubble: venture capitals rethink private companies in Q1 2022

GlobalData Healthcare

News

Covid-19 patent lawsuits: Will vaccine producers have to pay the bill?

Pricing and Market Access

Precise magnitude of hospital markups revealed in the US

Milena Izmirlieva

Features

Holistic thinking is prescribed for investors on World Health Day 2022

Comment

Will Russia’s invasion affect biopharmaceutical licensing agreements?

GlobalData Healthcare

Comment

Sanctions hit Russian investors with limited impact on foreign innovator drugs

GlobalData Healthcare

Comment

Fall from grace? What 2022 may have in stock for biopharmaceutical SPACs

GlobalData Healthcare

Pricing and Market Access

Is price control by stealth the future for the United States?

Milena Izmirlieva

Comment

Over $1bn raised in venture capital funding for gene editing in 2021

GlobalData Healthcare

Comment

Eli Lilly’s launch of tirzepatide will strengthen its T2D market share

GlobalData Healthcare

Features

Joe Biden’s global corporation tax deal: A prediction on what’s next

Features

Why has the WHO asked governments to delay Covid-19 booster jabs?

Michael Goodier

Comment

Amgen’s Otezla wins patent battle, but a marketing war may await

GlobalData Healthcare

Features

Waning Covid-19 vaccine efficacy: what does the data show?

Features

Insurers to squeeze JAK inhibitor access in chronic conditions after FDA safety warning

Features

Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite

Reynald Castañeda

Features

Novavax Covid-19 vaccine booster: safety and manufacturing questions remain

Reynald Castañeda

Features

Should UK children be vaccinated against chickenpox?

Comment

Setback of Seres’s late-stage candidate challenges microbiome space – register for free webinar

GlobalData Healthcare

News

Business optimism improves for the second straight month in July: Poll

Comment

Johnson and Johnson’s Covid-19 vaccine has another problematic rare side effect

GlobalData Healthcare

Comment

Chinese biosimilars surge between 2018 and 2020 due to new NMPA regulations

GlobalData Healthcare

Comment

Social factors must be addressed to ensure the protection of community health

GlobalData Thematic Intelligence

Features

Inside Philip Morris’ controversial Vectura acquisition

Features

How is activity in the pharma sector recovering from Covid-19’s impact?

Features

Is the pharma sector seeing the beginnings of an AI investment boom?

Comment

A new day for Alzheimer’s disease treatment after FDA approval of Biogen’s Aduhelm

GlobalData Healthcare